Related Experiment Videos
Cardiac transplantation: the final therapeutic option for the treatment of heart failure
M M Koerner1, J B Durand, J A Lafuente
1Baylor College of Medicine, Houston, Texas 77030, USA. mkoerner@bcm.tmc.edu
Insights
End-stage heart failure significantly impacts life quality and prognosis. Cardiac transplantation offers a final therapeutic option, with mechanical support systems aiding patient selection and management.
Area of Science:
- Cardiology
- Transplantation Medicine
- Medical Technology
Background:
- End-stage heart failure (EHF) severely diminishes quality of life and patient prognosis.
- Cardiac transplantation is a definitive treatment for irreversible EHF across all age demographics.
- Effective management of EHF necessitates advanced therapeutic strategies.
Purpose of the Study:
- To highlight the critical role of cardiac transplantation in managing end-stage heart failure.
- To emphasize the importance of interdisciplinary teams in candidate selection and management.
- To underscore the utility of mechanical circulatory support systems in heart transplantation.
Main Methods:
- Review of current practices in cardiac transplantation for end-stage heart failure.
- Analysis of the role of interdisciplinary teams in patient selection.
- Evaluation of mechanical circulatory support systems for bridging and recovery.
Main Results:
- Cardiac transplantation remains a vital option for end-stage heart failure patients.
- Experienced interdisciplinary teams enhance candidate selection and management of complex cases.
- Mechanical circulatory support systems are crucial for bridging to transplant and potential recovery.
Conclusions:
- Cardiac transplantation is a key therapy for end-stage heart failure.
- Interdisciplinary expertise and mechanical circulatory support are essential for successful transplantation outcomes.
- Optimized patient selection and support improve the prognosis for heart failure patients.
Abstract:
End-stage heart failure is still associated with a decrease in quality and prognosis of life. Cardiac transplantation remains the final extraordinary therapeutic option for the treatment of truly irreversible end-stage heart failure in all age groups. The selection process of candidates and the acceptance of patients with relative contra-indications is characterized by the experience and skills of an interdisciplinary transplant team, which should have access to different mechanical circulatory support systems for short-term or long-term use: bridging to transplant as well as for recovery.